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The AIMS of the presentation are to: 
 
• understand the importance of the management of the pain in 
neonates 
• neuroanatomical pathway of pain conduction in  neonate (term and 
preterm) 
• pathophysiological changes while painful procedures are performed 
 
• assess the level of pain experienced by the neonatal patient 
• tools for pain assessment in neonates containing both observational 
and pathophysiological signs in neonates 
 
• get the evidence based recommendations for the treatment of 
pain in neonates 
• the commonly used Clinical Guidelines for procedural pain and pain 
management 
• advantages and disadvantages for each of them 
Definition  
• The International Association for the Study of Pain 
(IASP) has developed a standard definition of pain, 
noting that pain is always subjective:  
 
"An unpleasant sensory and emotional experience 
associated with actual or potential tissue damage or 
described in terms of such damage" (www.lasp.org). 
• Pain can only be assessed by self-reporting of the person 
experiencing it. Lacking that, it may be inferred indirectly, from 
activation of nociceptor nerve pathways, by biochemical 
changes, by changes seen during functional neuroimaging, or 
by physiological and behavioural assessments.  
 
• Before the work by Anand and Hickey, it was thought that 
newborns could not feel pain, and, as a consequence, no 
adequate analgesic treatment was given. Two other reasons for 
this policy were the fear of the adverse events of analgesics 
and the lack of good pain assessment tools for infants. 
 
• The fact is that one can not take biopsies of babies’ nerves or 
brain tissue in order to study the neuronal anatomy and 
chemistry. Unless more powerful tools of functional 
neuroimaging to use while studying neonates are designed, the 
only mode of detecting neonatal pain are before mentioned 
indirect measures.  
 
 
 
Persistent myths about the neonatal pain 
Common misconceptions concerning newborn pain still 
exist and include:  
1. Newborns do not feel pain because their nervous systems are 
too immature. This false premise lies in the misbelief that 
newborns do not have the neurological substrate for the 
perception of pain because of lack of myelination, incomplete 
pain pathways from the periphery to the cortex, or immaturity 
of the cerebral cortex;  
2. Even if newborns do feel pain, they cannot remember it. 
3. Even if they feel or remember pain, it doesn't cause them 
harm. 
4. Even if newborns feel or remember pain, and, even if it is 
harmful to them, we cannot safely give them local or systemic 
analgesia or anesthesia, because it is too dangerous to 
administer it. 
 
Evidence about the neonatal pain experience 
The evidence to refute these misconceptions constitute the 
consensus statements by Anand and the AAP: 
 
• Peripheral receptors, nerve pathways, and the cerebral cortex can function 
properly  to process pain by mid-gestation (Anand, 1993). At birth, a neonate 
has developed the neural pathways for nociception and for experiencing 
pain, but the pain responses of a newborn baby is not simply a copy or 
immature version of that of an adult; 
 
• It is true that fetus and newborns have unmyelinated nerve fibers, but they 
can conduct the stimuli, although slower than the adults. Neuroanatomical 
components and neuroendocrine systems are sufficiently developed to allow 
transmission of painful stimuli in the neonate.  
 
• Compared with older age groups, newborns may experience a greater 
sensitivity to pain and are more susceptible to the long-term effects of 
painful stimulation. 
 
 
• The nerves of young babies respond more readily to noxious stimuli, 
because the neonatal threshold for sensitisation is decreased. Sensitisation 
refers to the phenomenon that a noxious event increases the sensitivity of 
the nociceptor system to another such event – or to a much milder or even 
entirely non-noxious event. The experience of severe pain to a mildly 
painful stimulus is called hyperalgesia, and pain in response to a stimulus 
which would normally not be painful is called allodynia. This happens in 
adults and babies, but in babies this occurs more quickly and the sensitised 
area is larger than in adults, for the same initial stimuli. 
 
• The pathways that descend from the brain to the spinal cord are not well 
developed in the newborn, so the ability to reduce or inhibit nociception 
via central brain mechanisms is limited 
 
• A lack of behavioral responses (including crying and movement) does not 
necessarily indicate a lack of pain. 
 
• Analgesia, sedation, and anesthesia can be safely provided to newborns in 
most circumstances. 
 
And at the end, considering many other reasons which 
probably still need to be discovered, a noxious event which 
appears minor to adults, can have unexpectedly 
widespread effects in the baby’s nervous system; it is 
sensed more intensely and potentially more diffusely than 
it would be in the adult, thus causing more deleterious 
effects on the neonatal health and wellbeing. 
• In addition to being more sensitive to start with, the 
neonate's nervous system seems much more active than 
that of an adult in transforming its connections and 
central nerve pathways in response to stimuli.  
• This reshaping - also called plasticity - involves both 
structural and chemical changes of the nervous system. It 
has been shown to occur in response to noxious events 
in the short term, and there are indications that such 
changes, once established, can persist until adult life. 
What precisely this implies for later childhood and adult 
life is as yet unclear, but the present feeling is that this 
potential for long term harm is a valid reason for working 
towards more effective management of neonatal pain. 
 
• Newborns are as sensitive to pain as adults, AND preterm 
infants are even more sensitive to pain. Neurotransmitters 
in the dorsal horn of the spinal cord are associated with 
nociception and increased somatosensory excitability in 
the preterm spinal cord.  
 
• On the other hand, neurotransmitters in descending 
inhibitory nerve fibers are only present at term. Thus, 
there is diminished inhibition of pain in premature infants. 
 
 
All levels of conduction and reversal pathway in both, 
neonate and adult, are presented in the next diagram.  
 
 
A diagram to show how larger dorsal horn receptive fields can lead to reduced sensory 
thresholds in third-order cells. DRG= dorsal root ganglion. 
Difference in response 
Repeated tissue damage in newborn infants will naturally activate 
primary  sensory neurons in the skin and underlying tissues. In many 
ways, these afferents respond in a similar way to those of adults. 
 
Neurotrophic factors will have more far-reaching effects if 
administered or up regulated in the neonatal period. The 
physiological properties of primary sensory neurons are highly 
influenced by the levels of neurotrophic factors in the skin during a 
critical period of development. 
 
The up-regulation of neurotrophic factors provides a likely 
explanation for the observation that early skin wounds lead to long-
term hyper-innervation and hypersensitivity of the injured area. 
Tissue damage in the early postnatal period in rats causes a 
profound and lasting sprouting response of the local sensory nerve 
terminals, leaving an area of hyper innervation in the wounded area 
that extends into adulthood 
Difference on central level 
The region of secondary hyperalgesia and allodynia that surrounds an 
area of tissue damage results from central synaptic rather than  
peripheral receptor alterations. The hyper-excitability of sensory 
neurons in the dorsal horn of the spinal cord and brainstem that 
follow inflammation is termed central sensitization in the newborn, 
the synaptic linkage between afferents and dorsal horn cells is still 
weak and electrical stimulation often evokes only a few spikes at long 
and variable latencies.  
 
Expression in the neonatal spinal cord show sawider distribution than 
in the  adult and decreases over the first postnatal 3 weeks. Different 
combinations of subunits will affect desensitization, ionic 
permeability, and current/voltage relationships. There are also 
changes in the distribution of the flip-flop variants with postnatal age; 
the flip variants are generally more sensitive to agonists than the flop, 
resulting in higher levels of depolarization from glutamate release 
(Watanabe and others1994).  
The implications of these findings on immature 
sensory processing in the spinal cord are not clear. 
Another important feature of infant dorsal horn cells is 
that their receptive fields are larger, that is, occupy a 
relatively larger area of the body surface, than in 
adults. The fields gradually diminish over the first 2 
postnatal weeks 
 
The persistent pain response of the infant in intensive 
care will depend on the ability of the developing 
sensory nervous system to activate mechanisms of 
peripheral and central sensitization. 
 
C-fiber-evoked activity matures after the first postnatal 
week in rats, and from P10, repetitive C-fiber 
stimulation produces a classical “wind-up” as reported 
in the adult dorsal horn in 18% of cells.  
Descendent pathways 
• Another contributory factor will be the 
immaturity of descending inhibition. It is well 
established in adults that descending 
pathways originating in higher centers can 
modulate the output of spinal nociceptive 
neurons and are activated in the presence of 
persistent pain 
 
The risk in Neonatal intensive care units 
(NICUs) 
The survival of preterm infants is dependent on highly 
sophisticated intensive care, associated with an exceedingly 
high number of painful procedures. This is particularly true for 
infants with extremely low gestational ages (GAs) who also 
receive less analgesia. 
 
Repeated pain exposures during critical windows of central 
nervous system development are associated with permanent 
changes in peripheral, spinal, and supraspinal pain processing, 
neuroendocrine function, and neurologic development. These 
changes can be manifested by alterations in pain thresholds, 
stress responses, cognitive function, behavioral disorders, and 
long-term disabilities. 
 
• Preterm infants born before 32 weeks’ gestation often 
require intensive care treatment to support their vital 
functions. Pain in these preterm infants has often been 
subject to study.  
 
• Late pre-term infants born between 32 and 37 weeks’ 
gestation usually do not need intensive care treatment, 
but, after a late preterm delivery, these newborns more 
frequently require intravenous fluid supply or medication 
in comparison with term infants.  
 
Despite this knowledge, many painful procedures in NICUs 
are performed without pharmacologic or non-pharmacologic 
analgesia.  
 
 
 
 
Painful Procedures Commonly Performed in the Neonatal 
Intensive Care Unit 
 
 
Diagnostic 
 
• Heel lancing 
• Arterial puncture 
• Endoscopy 
• Lumbar puncture 
• Suprapubic bladder tap 
• Venipuncture 
• Eye examination (Retinopathy of prematurity ) 
Therapeutic  
• Bladder catheterization 
• Central line and chest tube insertion/removal 
• Dressing change 
• Gavage tube insertion 
• Intramuscular injection 
• Laser therapy for retinopathy 
• Peripheral venous catheterization 
• Mechanical ventilation 
• Removal of adhesive tape 
• Suture removal 
• Tracheal intubation/extubation 
• Ventricular tap 
• Surgical interventions 
 
 
 
Why bother with newborn pain 
relief? 
 
 • Repeated episodes of pain in NICU do occur 
• Stressful for parents 
• Humane to help the patients 
• Immature nervous system cannot modulate 
effectively 
• Long term effects are documented 
• Pain habituation may alter the preterm brain 
 
Consequences of newborn pain 
Newborn pain, which itself is generally a consequence of 
intervention, has immediate, short term and long term 
consequences.  
 
• Newborn infants subjected to a variety of noxious stimuli have 
immediate hormonal, physiological and behavioral responses 
 
• Term and preterm infants behave differently in their short 
term response to pain. Prior pain experience in healthy, term 
babies appears to increase subsequent behavioral response to 
pain. By contrast, in preterm infants prior pain experience 
appears to diminish subsequent behavioral response to pain. 
 
 
• The long term consequences constitute an emerging field of 
research and importance as the possible impact of multiple, 
neonatal pain exposure in NICU on neurodevelopment, 
potentially contributes to later problems with attention, learning 
and behavior. 
 
• Painful neonatal experiences DO have long-term consequences, 
and even if not expressed as conscious memory, memories of pain 
maybe recorded biologically and alter brain development and 
subsequent behavior. Taddio et al reported that circumcised boys 
had higher pain and cry scores during routine immunization at 4-6 
months of age than uncircumcised boys.  
 
 
 
Immediate responses of infants to pain 
 Physiological changes 
Behavioral changes 
Hormonal changes 
Autonomic changes 
Body movements 
 
Physiological changes are presented as increase in: 
• Heart rate and blood pressure 
• Respiratory rate 
• Oxygen consumption 
• Mean airway pressure 
• Muscle tone 
• Intracranial pressure 
 
Behavioural changes 
 
Change in facial expression: 
• Grimacing 
• Screwing up of eyes 
• Nasal flaring 
• Deep nasolabial groove 
• Curving of the tongue 
• Quivering of the chin 
 
 
Body Movements 
 
•Finger clenching 
•Thrashing of limbs 
•Writhing 
•Arching of back 
•Head hanging 
Hormonal changes 
 
Increased release of: 
• Cortisol 
• Catecholamines 
• Glucagon 
• Growth hormone 
• Renin 
• Aldosterone 
• Antidiuretic hormone 
 
Reduced secretion of: 
• Insulin 
 
Autonomic changes 
 
•Mydriasis 
•Sweating 
•Flushing 
•Pallor 
 
Pain assessment: Could the pain be measured? 
The kind of structural and functional changes of the developing pain 
pathways depends on the moment, location, and kind of pain 
stimulus. While self-report, usually by using a linear analog scale, is 
regarded as the most reliable indicator of pain and considered the 
gold standard, neonates cannot verbalize their pain and thus depend 
on others to recognize, assess and manage their pain. 
 
Pain assessment tools were developed to measure pain in newborns 
as objectively as possible. There are pain assessment tools for 
procedural pain, postoperative pain, and prolonged pain. 
 
All pain assessment tools are based on the degree to which changes 
are expressed, alone or in combination. The most explored are 
following assessment tools for pain in neonates. 
 
 
Commonly Used Methods for Assessment of 
Pain in Newborns 
  
Premature Infant Pain Profile (PIPP) 
• Gestational age 
Behavioral state 
Heart rate 
Oxygen saturation 
Brow bulge 
Eye squeeze 
Nasolabial furrow 
• Scores vary between 0 (no pain) and 21 (maximum pain) 
 
• Interrater and intrarater Reliability > 0.93 
• Face, content, construct-acceptable in preterm and term neonates 
• Feasibility and utility established at bedside 
Neonatal Facial Coding Scale (NFCS) 
• Brow bulge 
Eye squeeze 
Nasolabial furrow 
Open lips 
Stretch mouth 
Lip purse 
Taut tongue 
Chin quiver 
Tongue protrusion 
 
• Interrater and intrarater Reliability > 0.85 
• Face, content, construct, and convergent (r = 0.89) 
• Feasibility established at bedside 
 
 
 
 
Neonatal Infant Pain Scale (NIPS) 
• Facial expression 
Cry 
Breathing patterns 
Arms 
Legs 
State of arousal 
 
• Interrater reliability >0.92 
• Face, construct, and concurrent (r= 0.53-0.84) 
• Fisibility not established 
CRIES Score 
• Crying 
Requires increase Oxygen administration 
Increased vital signs 
Expression 
Sleeplessness 
 
• Interrater reliability > 0.72 
• Face, content, discrimination, and concurrent (r = 0.49-0.73) 
• Nurses preferred CRIES over another scale 
BPSN —Bernese Pain Scale for Neonates 
• The BPSN contains 9 items, each scored 0-3 points:  
• 3 physiologic  
• heart rate, respiratory rate, and oxygen saturation 
• 6 behavioral  
• grimacing, body movements, crying, skin color, sleeping patterns, 
consolation items.   
• Higher scores for the behavioral items and greater changes 
in the physiologic items indicate deeper pain, whereas a 
total score of <11 is considered non-painful (sensitivity 
100.0% and specificity 89.4%).  
 
• Initial psychometric testing of the BPSN demonstrates good 
construct validity with differentiation between painful and 
non-painful procedures  
• intrarater reliability r= 0.98-0.99  
• inter-rater reliability correlation coefficients r= 0.86-0.97 
 
COMFORTneo 
The COMFORTneo scale is a pain assessment tool 
modified 
from the COMFORT behavioral scale. The 
COMFORTneo scale was validated for prolonged 
pain in 2009, but not for procedural pain. 
 
The COMFORTneo scale measures alertness, 
calmness, respiratory response or crying, body 
movement, facial tension, and muscle tone.  
 
Scores vary between 6 (no pain) and 30 (maximum 
pain). 



 
The general principles for the prevention and 
management of pain in newborns 
 
• Pain in newborns is often unrecognized and undertreated. 
Neonates do feel pain, and analgesia should be prescribed 
when indicated during medical care. 
 
• If a procedure is painful in adults, it should be considered 
painful in newborns, even if they are preterm. Adequate 
treatment of pain may be associated with decreased clinical 
complications and decreased mortality. 
 
• The appropriate use of environmental, behavioral and 
pharmacological interventions can prevent, reduce or 
eliminate neonatal pain in many clinical situations. 
 
• Sedation does not provide pain relief, but may mask the 
neonate's response to pain. 
 
• Clinical units providing health care to newborns should develop 
written guidelines for the management of neonatal pain. 
 
• When pain is prolonged, striking changes occur in the infant’s 
physiologic and behavioral indicators. During episodes of 
prolonged pain, neonates enter a state of passivity with few, if 
any, body movements; an expressionless face; decreased heart 
rate and respiratory variability; and decreased oxygen 
consumption, all suggestive of a marked conservation of 
energy.  
 
• Prolonged or repeated pain also increases the response elicited 
by future painful stimuli (hyperalgesia) and even by usually 
nonpainful stimuli (allodynia). Therefore, pain scales that are 
used in postoperative neonates should be sensitive to the 
changes in response that can occur when pain is prolonged. 
Systematic approach to pain management 
• Prevention, limiting, avoiding noxious stimuli 
 
• Assessment of neonatal pain by standardized 
methods with demonstrable validity, reliability and 
clinical utility 
 
• Treatment including non-pharmacological 
(behavioural) and pharmacological 
 
Identification of  the 
source of pain 
Pain assessment (scale) 
Standards, guidelines and policies 
Prevention of painful procedures 
Specific Pain assessment scales 
Procedural 
pain 
Prolonged 
pain 
Pain reassessment 
use of the same scale 
Pharmacological  
agents 
Reduction of painful procedures 
• Clearly, the most effective way of reducing minor procedural pain in the 
neonate is to reduce the number of procedures performed.  
 
• There currently is a paucity of research regarding effective ways to 
accomplish this, but strategies for reducing the number of procedures 
that neonates experience should be developed and their effectiveness 
should be tested.  
 
• Such an approach might include reducing the number of bedside 
disruptions in care.  
 
• Other strategies might include bundling interventions, eliminating 
unnecessary laboratory or radiographic procedures, using 
transcutaneous measurements when possible, and minimizing the 
number of repeat procedures performed after failed attempts. 
Prevention  
• Environment should be as conducive as possible to the well 
being of the neonate and family 
 
• Avoiding unnecessary noxious stimuli (acoustic, visual, 
tactile, vestibular) 
 
• Minimizing painful or stressful procedures (use of central 
lines-umbilical, rather than peripheral; central or peripheral 
long lines rather than repeated IV lines for longer term use; 
arterial line rather than repeated arterial stabs) 
 
• Non-invasive measurement where possible (oximeter in 
small babies,  bilirubinometer prior to blood sampling) 
 
 
Prevention  
The prevention of pain in neonates should be the goal of all caregivers, 
because repeated painful exposures have the potential for deleterious 
consequences.  
 
Neonates at greatest risk of neurodevelopmental impairment as a result of 
preterm birth (ie, the smallest and sickest) are also those most likely to be 
exposed to the greatest number of painful stimuli in the NICU and prone to 
bad outcome.  
 
Although there are major gaps in the knowledge regarding the most effective 
way to prevent and relieve pain in neonates, proven and safe therapies are 
currently underused for routine minor, yet painful, procedures.  
 
Every health care facility caring for neonates should implement an effective 
pain-prevention program, which includes strategies for minimizing the 
number of painful procedures performed 
 
Reducing pain from bedside care 
procedures 
 
• Neonates in the NICU often experience painful procedures 
during routine care, such as needle insertions, suctioning, 
gavage-tube placement, and tape removal, as well as stressful 
disruptions, including diaper changes, chest physical therapy, 
physical examinations, nursing evaluations, and exposure to 
environmental stimuli.  
 
• Despite increased awareness by caregivers that neonates in 
the NICU frequently experience pain, effective pain relief for 
these routine procedures is often underused.  
 
Reducing pain from bedside care procedures 
1. Care protocols for neonates should incorporate a principle of minimizing the 
number of painful disruptions in care as much as possible. 
 
2. Use of a combination of oral sucrose/glucose and other non-pharmacologic pain-
reduction methods (nonnutritive sucking, kangaroo care, facilitated tuck, swaddling, 
developmental care) should be used for minor routine procedures. 
 
3. Topical anesthetics can be used to reduce pain associated with venipuncture, 
lumbar puncture, and intravenous catheter insertion when time permits, but are 
ineffective for other painful minor procedures.  
 
4. The continuous infusion of morphine in ventilated preterm neonates may not 
effectively prevent acute pain from minor painful procedures and may increase 
adverse events. However, there are other effective methods of preventing minor 
procedural pain in neonates, which should be used routinely.  
 
5. The routine use of continuous infusions of morphine, fentanyl, or midazolam in 
chronically ventilated preterm neonates is not recommended because of concern 
about short-term adverse effects and lack of long-term outcome data. 
Assessment and reassessment 
• Premature Infant Pain Profile (PIPP) 
 
• Neonatal Facial Coding Scale (NFCS) 
 
• Neonatal Infant Pain Scale (NIPS) 
 
• CRIES Score 
 
• BPSN —Bernese Pain Scale for Neonates 
 
• COMFORTneo for prolonged pain 
 
 
 
 
 
 
Clinical Guidelines 
Evidence based medicine 
 
 
• Up to date recommendations: AMERICAN ACADEMY OF 
PEDIATRICS; 2006 and revision 2012,  
• Committee on Fetus and Newborn, Section on Surgery, and 
Section on Anesthesiology and Pain Medicine.Position statement. 
CANADIAN PAEDIATRIC SOCIETY. 2007 
• Guideline summary NGC 8271: NP management of procedural 
pain in breastfeeding infant (ABM Clinical protocol 23); 2010 
• Royal Prince Alfred Hospital policy (Clinical Guidelines) Neonatal 
Pain Policy, 2009 
• Murki S and Subramanian S. Sucrose for analgesia in newborn 
infants undergoing painful procedures: RHL commentary (last 
revised: 1 June 2011). The WHO Reproductive Health Library; 
Geneva: World Health Organization. 
• Cochrane reviews: Two reviews, Revision 2009 and 2012 
• Italian society of neonatology, Management of Procedural pain; 
2009 
Objectives 
These updated statements are intended for health care 
professionals who care for neonates (preterm to 1 month of 
age). Strategy of pain management contains:  
1. Emphasize that despite increased awareness of the 
importance of pain prevention, neonates in the NICU continue 
to be exposed to numerous painful minor procedures daily as 
part of their routine care; 
 
2. Importance of precise assessing neonatal pain by health 
care professionals; 
 
3. Implementation of effective strategies to prevent and treat 
pain associated with routine minor procedures; and 
 
4. Review appropriate methods to prevent and treat pain 
associated with surgery and other major procedures. 
Grades of recommendations and level of evidence 
A  At least one good-quality meta-analysis of randomized controlled trials  
 (RCTs)  or a sufficiently powered good-quality RCT with a very low risk of  
 bias, irectly applicable to the target population 
B  A body of evidence including good-quality systematic reviews of case–control or 
 cohort studies directly applicable to the target population, or good-quality 
 `case–control or cohort studies with a very low risk of confounders or bias and a 
 high probability of the relationship being causal. Evidence extrapolated from 
 good-quality meta-analyses, systematic reviews of RCTs or RCTs with a very low 
 or low risk of bias 
C  A body of evidence including well-conducted case–control or cohort studies 
 with a low risk of confounders or bias and a moderate probability of the 
 relationship not being causal, directly applicable to the target population and 
 demonstrating overall consistency of results, or evidence extrapolated from 
 good-quality systematic reviews of case–control or cohort studies, or good-
 quality case–control or cohort studies 
D  Non-analytical studies, e.g. case reports, case series or evidence extrapolated 
 from well-conducted case–control or cohort studies with a very low risk of bias 
GPP Good practice points; Recommended practice, based on the clinical experience 
 of the group that developed the guidelines  
   
Modified from the SIGN Guidelines Developer’s Handbook 2008 
General principles 
• Environmental, behavioral and non-pharmacological comfort measures are 
recommended for each procedure, e.g. the use of a pacifier with sucrose combined 
with distraction techniques. The pharmacological options used in combination with 
these measures can have additive or synergic effects in controlling procedural pain 
and stress. 
• For planned procedures, such as blood sampling or creating a vascular access, the 
optimal baseline state of quiet wakefulness should be obtained before starting the 
procedure. 
• If possible, do not interrupt sleep; plan the procedure far from mealtimes and from 
any other painful invasive procedures to allow for recovery. 
• Conduct the procedure in a calm and relaxing environment, reducing noxious stimuli 
(light and noise) as much as possible. 
• During the procedure, the neonate should preferably be contained in warm sheets 
and accompanied during and after the procedure. 
• Monitoring pain and stress as the fifth vital sign during ongoing analgesia or invasive 
procedures with scales validated for infants may facilitate the fine tuning of 
analgesic measures and improve awareness of how the newborn feels. 
• At the end of the procedure, continue to monitor the physiological parameters until 
they return to the baseline state. 
• Plan no other invasive procedures for at least 2 h after the procedure 
 
Heel lancing 
 Venipuncture is the preferred method for blood sampling in term newborns 
as it is less painful, more efficient and requires less resampling. This approach 
may not apply to the care of extremely preterm infants [A].  
 
Environmental measures 
• Warming the heel is ineffective for heel lancing [C] 
 
• Do not squeeze the heel, which must be well perfused and squeezing is 
itself a cause of pointless pain [D]. It is the most painful part of the 
procedure  
 
• Use techniques to distract the neonate and provide stimuli to stop pain 
transmission to the cerebral cortex, such as sensorial saturation (a 
technique consisting in the mother or nurse massaging and talking to the 
baby while administering oral glucose before the puncture) [B] 
 
• Consider involving the mother in procedures whenever possible, using skin-
to-skin contact or breastfeeding during non-routine sampling [B]. The 
efficacy of breastfeeding during multiple painful procedures has not been 
documented. Ensure the parent or carer holds the infant,  OR use 
swaddling, containment by flexing and holding the infant and employ 
multisensory stimulation; 
 
• Use an automatic lancet rather than a manual lancet [B]  
 
Non-pharmacological measures 
• Use sucrose and non-nutritive sucking (NNS) or human milk [A]  
 
• The use of oral sucrose alone has recently proved ineffective in the case of 
repeated heel lances in term infants in the first 2 days of life [B]  
 
• Alternatively, use a glucose solution [C]  
• The use of less-concentrated solutions is recommended in premature 
infants because solutions with higher concentrations of  
sucrose/glucose (24–33%) have a high osmolarity, up to 1000 mOsm [D] 
 
• The use of NNS seems to have a synergic effect with the sweet taste and 
is recommended, whenever possible [B] 
 
• The use of multiple doses for a given procedure (2 min before, 
immediately before and 2 min after heel lancing) seems more effective 
than a single dose [B]  
 
• The long-term safety of multiple doses of oral sucrose has not been 
demonstrated [A]  
 
Pharmacological measures 
• The use of EMLA cream is not recommended, as it is ineffective for heel 
lancing pain [B]  
• Pre-emptive analgesia with paracetamol before the procedure is not 
recommended, as it is ineffective [A]  
 
 
Intramuscular or subcutaneous injections  
Environmental measures 
• It is preferable to administer drugs intravenously 
wherever 
 possible [GPP]. 
• Adopt all the environmental measures mentioned in the 
 heel lancing section. Choose a smaller gauge needle 
wherever possible [GPP]. 
 
Local pharmacological measures 
• Apply EMLA cream (0.5–1 g) 60 min before the procedure 
[B]  
 
NOTE: Application of EMLA cream (0.5-1g) 60-90 minutes 
prior to injection (for single injection) was not considered 
practical for Vit K injection as to ensure maximum 
compliance this is given shortly after birth at most 
hospitals 
 
 
Nasogastric or orogastric tube insertion 
 
• Use a pacifier with sucrose [GPP] 
 
• Use holding, swaddling or containment by flexing 
and holding the infant. Use sucrose and non-
nutritive sucking (NNS) or human milk [A]  
 
• Use a gentle technique with appropriate 
lubrication ensuring the head is in the neutral or 
"sniffing" position, and inserting the tube in a 
vertical direction at right angles to the face 
 
Central venous catheter insertion by surgical cut-down 
Non-pharmacological measures 
• Use sucrose and NNS or human milk during the preparatory phase 
whenever possible [GPP] 
 
Local pharmacological measures 
• Apply EMLA cream 60 min before the procedure [C] or proceed 
directly with the subcutaneous infiltration of lidocaine 1% at a dosage 
of 2–4 mg/kg buffered with sodium bicarbonate 8,4% in 1:10 dilution 
[D] The buffered solution can reduce the pain of the local infiltration 
Systemic pharmacological measures 
• Sedation: administer a slow i.v. bolus of fentanyl [D] 
 and midazolam, as necessary [GPP], or an i.v. bolus of ketamine[GPP]. 
• Closely monitor the patient and anticipate any need for ventilatory 
and circulatory support in the event of respiratory depression [GPP]. 
• General anaesthesia: administer an i.v. bolus of fentanyl and a muscle 
relaxant [GPP]  
 
Lumbar puncture 
 
Environmental measures 
 
• Whichever position is chosen (on the side, sitting in the crib or on the 
nurse’s or mother’s arm), avoid any extreme flexion of the neck and knees 
towards the chest because this can cause significant hypoxemia, especially 
in critical patients, as well as carrying a risk of vertebral fractures [D]. 
 
• It is advisable to perform LP with an atraumatic needle, as it separates the 
fibers of the yellow ligament without severing them, and early stylet 
removal improves the success rates [C]. 
 
• This avoids post-LP fluid exudation and the risk of secondary headache 
and the, albeit rare, onset of epidermoid tumours in the spinal canal [D]  
 
Non-pharmacological measures 
• Use sucrose and NNS or human milk [GPP] 
 
Local pharmacological measures 
• Apply EMLA cream to the puncture site 60 min before the procedure [A]  
 
• The use of other local anaesthetics, such as subcutaneous lidocaine 
infiltration, is not recommended as a front-line anaesthetic measure [C], 
and there are no reports on its use for deeper anaesthesia after EMLA. 
 
Systemic pharmacological measures 
 
• The use of systemic analgesia and sedation with a slow i.v. opiate bolus 
can be recommended in some cases if the neonate is intubated. If term 
infants are not intubated, a bolus of midazolam can be suggested if the 
infant is particularly restless, monitoring the vital signs (especially blood 
pressure). After the procedure, keep the neonate supine, continue with 
pain control measures and monitor the physical parameters until they 
return to the baseline state [GPP]. 
 
• Consider using paracetamol for the treatment of headache following 
subarachnoid puncture [D] 
Endotracheal intubation 
Many different approaches are reported and a great 
variety of drugs are used, alone or in combination, as 
premedication for elective intubation in neonates.  
 
• Combinations of opiate and muscle relaxant [B]  and 
remifentanil 
 and midazolam [B],  or propofol [B], thiopental [B]  and 
ketamine [D] have been proposed.  
 
• Using appropriate analgesia and sedation during 
tracheal intubation 
 facilitates the procedure (fewer attempts and shorter 
times), reducing potentially harmful physiological 
fluctuations and pain [A] 
 
• In nasal intubation, small doses (0.3 mL/kg) of lidocaine 
gel 2% may be useful [D]  
 
Endotracheal suction 
This is considered a stressful procedure and may be 
associated with the same physiological responses 
that accompany other painful procedures 
 
• Use a pacifier; may consider giving sucrose 
 
• Use swaddling or containment, by holding the infant 
 
• Consider continuous intravenous infusion of opioids 
(morphine) or slow injection of intermittent opioid doses 
(morphine), although this may not be indicated in preterm 
infants 
 
Chest tube insertion 
Anticipate the need for intubation and ventilation in neonates breathing 
spontaneously 
Non-pharmacological measures 
• Apply appropriate behavioral pain control measures [GPP] 
 
Local pharmacological measures 
• If the procedure is not urgent, apply EMLA cream to the puncture site[GPP]. 
If it is urgent, proceed directly with subcutaneous lidocaine 1% infiltration 
[D]  
 
Systemic pharmacological measures 
• In intubated and ventilated neonates, administer a slow i.v. opiate bolus [D] 
In non-intubated neonates, consider a bolus of ketamine, except for VLBWI, 
but anticipate the need for intubation and ventilation in neonates breathing 
spontaneously [D]  
• After the procedure, consider the use of bolus or continuous venous 
infusions of opiates, monitoring the pain scale [D]  
Chest tube removal 
Non-pharmacological measures 
• Apply appropriate behavioural pain control 
measures [GPP] 
 
Local pharmacological measures 
• Apply EMLA cream to the site of insertion [D]. 
 
Systemic pharmacological measures 
• Consider a slow i.v. opiate bolus [GPP]. 
Screening for ROP  
Non-pharmacological and environmental measures 
• Perform the screening procedure away from meals 
[GPP]. 
• Use appropriate behavioural pain control measures 
and sucrose and NNS [A], or human milk [GPP]. 
• Conduct the ophthalmoscopy without using the 
blepharostate, the positioning of which causes pain 
[C] 
 
Pharmacological measures 
• In the case of RetCam screening, apply local 
anaesthesia with oxybuprocaine 0.4% or tetracaine 
1% eye drops and consider a slow i.v. opiate bolus or 
ketamine [D] 
Laser therapy for retinopathy of prematurity 
Non-pharmacological measures 
• During preparations for the procedure, adopt appropriate behavioral pain 
control measures [GPP] 
• Use a pacifier with sucrose 
• Consider slow intravenous opioid infusion (morphine) 
• Other approaches may include the use of short acting anesthetic agents 
• Consider oral paracetamol after extubation and use of a pain score. 
Pharmacological measures 
• In general, combine a local anaesthetic with a general anaesthesia, 
administering a slow i.v. opiate bolus in association with a muscle relaxant 
before intubation, or combine local naesthesia with sedation using low 
doses of opiates combined with midazolam or ketamine, supporting the 
airways with a positive pressure [D] 
• Nasopharyngeal prongs or a laryngeal mask are a valid alternative to 
ventilatory support during brief measures if the neonate has not already 
been intubated [D]  
• At the end of the procedure, arrange for postoperative analgesia for the 
first 24–48 h [D] 
 
 
Ongoing analgesia for routine NICU care and 
procedures 
• Reduce acoustic, thermal, and other environmental stresses 
 
• Use swaddling or containment, by holding the infant ± 
multisensory stimulation 
 
• Use a pacifier and if possible and safe to do so, give with 
sucrose (do not use routine, repeated doses of sucrose in 
infants < 31 weeks gestation) 
 
• Consider low-dose continuous infusion of morphine if patient 
is ventilated, although this may not be indicated in preterm 
infants  
 
• The use of midazolam is not recommended 
 
 
Interventions with evidence of benefit 
 
• Venipuncture is less painful than heel lancing for blood 
sampling in newborns 
• Sucrose is safe and effective in reducing pain from heel 
lancing 
• Sucrose is safe and effective in reducing pain from 
venepuncture and heel lancing in preterm infants 
• Pacifiers (dummies), non nutritive sucking, rocking, are 
effective in reducing pain responses 
• Sucrose with pacifiers are effective in reducing pain 
responses in newborn infants 
• Sucrose and holding are effective in reducing pain responses 
 
 
• Multisensory stimulation (massage, voice, eye contact and 
perfume smelling) with oral glucose and sucking is most 
effective in reducing pain responses to heel lancing in term 
and preterm infants 
• Breast feeding is effective in reducing pain responses during 
heel lancing in healthy newborns 
• Skin to skin contact is effective in reducing pain responses 
during heel lancing in newborns 
• Automated lancets are superior to conventional lancets (less 
need for repeat punctures, shorter procedure time, increased 
volume of blood collected, reduction in haemolysed blood 
samples) 
• A fully retractable automatic lancet is superior to a partially 
retractable automatic lancet (less pain, less time to perform, 
fewer punctures but more expensive) 
 
 Interventions with no evidence of benefit or 
with evidence of harm 
 
• EMLA cream, topical amethocaine, lignocaine ointment, oral 
paracetamol are not effective for heel lancing pain 
• Warming the heel does not reduce pain or aid blood 
collection during heel lancing 
• Midazolam maybe associated with a higher incidence of 
adverse neurological events and longer NICU stay 
• Routine repeated use of sucrose analgesia in preterm 
neonates <31 weeks post-conceptional age in the first week 
of life may result in poorer neurobehavioural development 
and physical outcomes 
• Routine morphine infusion in preterm ventilated newborns 
has no measurable analgesic effect and no effect on poor 
neurological outcome 
 
 
 
 
 
Recommendations 
Assessment of pain and stress in the neonate 
 
1. Caregivers should be trained to assess 
neonates for pain using multidimensional tools. 
 
2. Neonates should be assessed for pain routinely 
and before and after procedures. 
 
3. The chosen pain scales should help guide 
caregivers in the provision of effective pain relief. 
 
Reducing pain from surgery 
 
1. Any health care facility providing surgery for neonates should have an 
established protocol for pain management. Such a protocol requires a 
coordinated, multidimensional strategy and should be a priority in 
perioperative management. 
2. Sufficient anesthesia should be provided to prevent intraoperative pain 
and stress responses to decrease postoperative analgesic requirements. 
3. Pain should be routinely assessed by using a scale designed for 
postoperative or prolonged pain in neonates. 
4. Opioids should be the basis for postoperative analgesia after major surgery 
in the absence of regional anesthesia. 
5. Postoperative analgesia should be used as long as pain-assessment scales 
document that it is required. 
6. Acetaminophen can be used after surgery as an adjunct to regional 
anesthetics or opioids, but there are inadequate data on pharmacokinetics at 
gestational ages less than 28 weeks to permit calculation of appropriate 
dosages. 
 
Reducing pain from other major procedures 
 
1. Analgesia for chest-drain insertion comprises all of the 
following: 
• general nonpharmacologic measures; 
• slow infiltration of the skin site with a local anesthetic before 
incision unless there is life-threatening instability; and 
• systemic analgesia with a rapidly acting opiate, such as 
fentanyl. 
2. Analgesia for chest-drain removal comprises the following:  
• general nonpharmacologic measures and 
• short-acting, rapid-onset systemic analgesic. 
3. Although there are insufficient data to make a specific 
recommendation, retinal examinations are painful, and pain-
relief measures should be used. A reasonable approach would 
be to administer local anesthetic eye drops and oral sucrose. 
4. Retinal surgery should be considered major surgery, and 
effective opiate-based pain relief should be provided. 
Challenges and major dilemma 
regarding pain management in 
neonates 
Sucrose for procedural pain in infants (2012) 
The use of oral sucrose has been the most extensively studied pain 
intervention in newborn care to date. More than 150 published studies 
relating to sweet-taste-induced calming and analgesia in human infants have 
been identified, of which 100 (65%) include sucrose.  
 
With only a few exceptions, sucrose, glucose, or other sweet solutions 
reduced pain responses during commonly performed painful procedures in 
diverse populations of infants up to 12 months of age. 
 
Sucrose has been widely recommended for routine use during painful 
procedures in newborn and young infants, yet these recommendations have 
not been translated into consistent use in clinical practice. 
 
One reason may be related to important knowledge and research gaps 
concerning analgesic effects of sucrose. Notably, the mechanism of sweet-
taste-induced analgesia is still not precisely understood, which has 
implications for using research evidence in practice.  
 
More research is needed about the understanding of the mechanisms of 
sucrose-induced analgesia; highlight existing evidence, knowledge gaps, and 
current controversies; and provide directions for future research and 
practice. 
This use of the term analgesia, defined by the International 
Association for the Study of Pain, is particularly open to criticism 
when describing effects of most analgesic agents. “Absence of 
pain,” based on observational measures (behavioral indicators 
including facial expressions, crying, body movements) and 
composite measures (behavioral and physiologic indicators plus 
other indicators such as behavioral state, nurses perception of pain) 
is rarely achieved, yet the term is widely used in neonatal pain 
studies. 
 
This, highlights the subjective nature and selection of terms and the 
lack of clarity surrounding the term “pain” in infants among 
clinicians and researchers. In addition, the emotional component of 
pain in infants is not able to be interpreted. Despite many years of 
debate, this lack of clarity of the definition and meaning of these 
terms still has an impact on the interpretation of infants’ responses 
to sucrose, especially because the mechanisms of sucrose are not 
fully understood in either animals or humans. 
 
 
• Despite the strong evidential base of analgesic effects of 
sucrose in newborn and young infants for single painful 
procedures, there remain knowledge gaps concerning the 
following: 
• Opioid pathways involved in mechanism of effect, 
especially in the developing infant; 
• Effectiveness when administered with concomitant opioid 
analgesics;  
• Effectiveness when administered concurrently with other 
pain management strategies such as skin-to-skin care;  
• Use, safety, and effectiveness when used repeatedly for 
extended periods in extremely low birth weight infants 
and sick infants requiring prolonged hospitalization.  
• Despite the extensive work, the mechanisms of analgesic 
effects of sweet solutions in human infants remain poorly 
understood. On the basis of animal studies, the key 
mechanism is believed to be sweet-taste-induced b-
endorphin release. However, elevated serum levels of b-
endorphin in response to oral sucrose has not been 
identified in human neonates. 
Prolonged use of sucrose raises important questions 
related to effectiveness and safety, although there is a 
paucity of data relating to long-term outcomes. 
Johnston et al reported that preterm infants ,31 weeks’ 
gestational age who received 10 doses of sucrose per 
24 hours in the first week of life, had poorer neurologic 
outcomes compared with infants who received fewer 
sucrose doses. 
 
No differences in any safety outcomes after consistent 
use of sucrose for preterm infants over the first month 
of life were reported in another study. 
 
These are the only studies that have reported on 
longer-term outcomes in infants after repeated 
sucrose use the same argument applies to glucose, 
because many studies have shown that glucose, if 
sufficiently concentrated, also reduces pain in infants. 
 
However, although basic science and clinical researchers and 
clinicians continue to address the knowledge and research gaps 
relating to analgesic effects and mechanisms of sucrose, we need 
to remain cognizant that untreated or poorly treated pain in fragile 
infants has well documented short-term adverse consequences 
and potential longer-term negative effects. 
 
Clinicians therefore have an ethical responsibility to minimize pain 
exposure; use sucrose appropriately for single painful procedures, 
along with other evidence-based strategies including NNS, 
kangaroo care, and breastfeeding when feasible, and monitor use 
and effectiveness of these strategies over short- and long-term 
periods.  
 
Importantly, clinicians’ decisions must be based on the best  
evidence available and not swayed by single studies or pervasive 
myths. 
 
Remaining knowledge and research gaps concern the mechanism of the effects of 
sucrose, determination of the best indicator or combination of indicators for 
assessing pain in infants, effectiveness and safety for repeated use in extremely 
preterm infants and critically ill infants,  effectiveness for infants exposed to 
antenatal methadone or receiving postnatal opioid analgesics, and best dosing 
regimes. 
 
CONCLUSIONS 
Profound research concerning pain-reducing properties of sucrose has been 
conducted over the past 25 years, with indisputable evidence that small volumes 
significantly reduce behavioral responses and composite pain scores to painful 
procedures in new-born and young infants.  
Recommendations for practice include using small volumes of sucrose for painful 
procedures only; avoiding use for calming irritable infants who are not undergoing 
procedures; giving solutions in aliquots over the duration of the procedure for 
prolonged procedures; avoiding use of.10 doses per 24 hours, especially during 
the first week of life; and using other effective  
strategies during painful procedures when feasible. Future research needs 
to address remaining areas of uncertainty with the ultimate aim of ensuring 
that no infant suffers unnecessary pain during painful procedures. 
Breastfeeding or breast milk for procedural pain in neonates. Shah 
PS, Aliwalas LL, Shah VS. Cochrane Database of Systematic Reviews, 
2006, Issue 3. Revision 2012 
It is recommended to limit the sucrose administration to 
newborns younger than 32 weeks postmenstrual age, because 
there is a negative association between the frequent use of 
sucrose in this group of patients and neurologic development at 
a postmenstrual age of 38 weeks. 
 
Another effective and safe non-pharmacologic intervention for 
treating procedural pain is breast-feeding or giving supplemental 
breast milk. 
 
A randomized controlled trial with 101 term infants 
demonstrated even lower PIPP scores during a heel lance 
puncture when the infants were given breastfeeding during the 
procedure than when they were given sucrose. 
 
Authors’ conclusions 
 
 
• If available, breastfeeding or breast milk should be used to alleviate 
procedural pain in neonates undergoing a single painful procedure 
compared to placebo, positioning or no intervention.  
 
• Administration of glucose/sucrose had similar effectiveness as 
breastfeeding for reducing pain.  
 
• The effectiveness of breast milk for repeated painful procedures is not 
established and further research is needed.  
 
• These studies should include various control interventions including 
glucose/ sucrose and should target preterm neonates 
 
• The effectiveness of several forms of non-pharmacologic interventions 
to treat procedural pain in infants has been proven with a high level of 
evidence. 
 
 
The use of sucrose with or without nonnutritive 
sucking is the most frequently studied intervention. 
 
Animal research suggests that sweet solutions like 
sucrose modulate pain through opioid mechanisms. 
 
Little research has been done in human newborns, and 
the findings reported thus far have been ambiguous. 
 
The greatest analgesic effect occurs when sucrose is 
administered ∼2 minutes before the painful stimulus. 
The analgesic effect lasts∼4 minutes 
 
The combination of sucrose with nonnutritive sucking 
provides better pain relief than both methods 
separately 
• Sucrose is recommended extensively for pain relief in 
preterm infants  and has shown to be highly effective and 
safe for  single procedures. Sweet taste solutions seem to 
trigger endogenous opioid and non-opioid pathways. 
 
• Facilitated Tucking (FT) is described as holding the  infant 
by placing a hand on his or her hands and feet and by 
positioning the  infant in a flexed midline position while in 
either a side-lying, supine, or prone position. This 
technique provides the infant with support and the chance 
to control his or her own body.  Several studies reported 
that FT stabilizes behavioral and physiologic states during 
single heel sticks and endotracheal suctioning, reducing 
the infant’s stress in coping with pain.  
 
• Although current evidence supports the effectiveness of 
NPIs for a single painful procedure, there is little research 
examining their effectiveness across repeated painful 
procedures.  
Management of pain in late preterm (2012) 
It was concluded that giving breast milk during a 
painful procedure is a non-invasive, safe and natural 
method for pain relief in late preterm infants.  
 
It can not be concluded that breast milk has a superior 
analgesic effect compared with sucrose in late preterm 
infants during a heel lance procedure, as was suggested 
for term newborns in preceding trials. 
 
It is recommended the use of expressed breast milk or 
sucrose if late premature neonates receiving a heel 
lance experience difficulties with breastfeeding 
Sucrose for analgesia in newborn infants undergoing painful procedures  
 Stevens B, Yamada J, Lee GY, Ohlsson A. Cochrane database of reviews, 
2013 
Sucrose is safe and effective for reducing procedural pain 
from single events. An optimal dose could not be 
identified due to inconsistency in effective sucrose 
dosage among studies. Further investigation on repeated 
administration of sucrose in neonates and the use of 
sucrose in combination with other non-pharmacological 
and pharmacological interventions is needed. Sucrose 
use in extremely preterm, unstable, ventilated (or a 
combination of these) neonates needs to be addressed. 
Additional research is needed to determine the 
minimally effective dose of sucrose during a single 
painful procedure and the effect of repeated sucrose 
administration on immediate (pain intensity) and long-
term (neurodevelopmental) outcomes. 
 
P L A I N L A N G U A G E S U M M A R Y 
 
Sucrose for analgesia in newborn infants undergoing painful 
procedures: 
• Healthcare professionals need strategies to reduce newborn 
babies’ pain. Sucrose (sugar) provides pain relief for newborn 
babies having painful events such as needles or heel pricks.  
• Pain medicine is usually given for major painful events (such 
as surgery), but may not be given for more minor events 
(such as taking blood or needles). Pain medicine can be used 
to reduce pain, but there are several other methods including 
sucking on a pacifier (dummy) with or without sucrose.  
• Researchers have found that giving sucrose to babies 
decreases their crying time and behaviors such as grimacing.  
• More research is needed to determine if giving repeated 
doses of sucrose is safe and effective, especially for very low 
birth weight infants or infants on respirators. 
• Although the authors of the Cochrane systematic 
review of sucrose analgesia in newborn infants could 
not establish an optimal sucrose dose, only small 
volumes are required, such as 0.1 to 1 mL or∼0.2 to 
0.5 mL/kg.  
 
• Researchers and clinicians should take into account 
tailoring doses based on context in which sucrose is 
to be used, including gestational and postnatal age 
of the infant, severity of illness, and the painful 
procedure being performed.  
 
• Finally, a consensus on the definition of “pain”  in 
infants may greatly assist pain researchers to use 
consistent terms and to use consistent outcome 
measurements in future studies.  
• Ability to feel and express pain;  
• Biological profile (age, gender, birth weight) 
•  painful situations occurrence 
Patient related 
factors 
• Individual factors (sensibility, empathy, motivation) 
• Technical factors (knowledge of assessment methods, 
drug availability and their adverse effects) 
Professional 
related factors 
• Established clinical protocols, compliance with them 
• Availability of resources, material and human 
Services related 
factors 
Conceptual model of use of analgesia in 
Neonatal intensive care  unit 
Sucrose and non nutritive sucking in the light 
of Baby Friendly Hospital Initiative 
• Do some pain relief methods interfere with the successful 
breastfeeding? (sucrose, dummy, non-nutritive sucking) 
 
• What is the cost-benefit ratio in such cases? 
 
• Do these procedures comply with BFH standards? 
 
• How will the external assessors react in such situations? 
 
• What is the method of choice for neonatal pain assessment? 
 
• Does it need special training? 
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